Cetera Investment Advisers Emergent Bio Solutions Inc. Transaction History
Cetera Investment Advisers
- $49.2 Billion
- Q1 2025
A detailed history of Cetera Investment Advisers transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 356,281 shares of EBS stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
356,281
Previous 277,247
28.51%
Holding current value
$2.16 Million
Previous $2.65 Million
34.68%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding EBS
# of Institutions
177Shares Held
38.3MCall Options Held
94.1KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$23.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$19.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$15.1 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$13.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$10.4 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $302M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...